Trial Profile
A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination With Azacitidine in Patients With 11q23-Rearranged Acute Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 23 Oct 2023
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary) ; Azacitidine (Primary) ; Pinometostat (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 14 Jan 2021 Status changed from active, no longer recruiting to completed.
- 14 Nov 2020 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2020 Planned End Date changed from 14 Jun 2020 to 14 Jun 2021.